News Desk, News Nation 360 : Indian Society for Assisted Reproduction (ISAR) Bengal in association with Medica Superspecialty Hospital, the largest private hospital chain in Eastern India organized a continued medical education seminar for practitioners in the fields of oncology and reproductive medicine at ITC Royal. The panel for the event included eminent doctors such as Dr Arunava Roy, Head of Gynae Oncology and Women Cancer Initiative at Medica Cancer Institute, Dr Kausiki Ray Sarkar, HOD, Fertility Unit, AMRI Medical Centre, Dr Siddhartha Chatterjee, President of ISAR, Bengal Dr Sudip Basu, President(elect) of ISAR, Bengal and Dr Sourav Datta, Senior Consultant & Director at Medica Oncology along with Ayanabh Deb Gupta, Co-founder & Jt. Managing Director, Medica Hospitals Pvt Ltd. The seminar participants received an in-depth briefing on the most recent developments in the fields' intersections and impacts on one another. Addressing the attendees, Dr Arunava Roy, Head of Gynae Oncology and an acclaimed Robotic surgeon at Medica Cancer Institute stated that these days, couples are opting to start a family at an older age than in their previous generations. Over the past decade, more women are presenting with cancer at a younger age (<40 years). With the conjunction of these issues, a challenging scenario is emerging, where young cancer survivors seek fertility options past their cancer recovery. Oncol-fertility is a relatively new field that focuses on the amalgamation of oncology and reproductive medicine, to preserve the fertility of women with curable malignancies. Cancer treatments such as surgery, chemotherapy, and radiation therapy harm fertility. Therefore, cancer treatment must be reconsidered in light of fertility preservation in these young women.  It is also noteworthy that robotic surgery has a crucial role in fertility enhancement and preservation as it is a high-precision procedure causing less tissue trauma thereby maintaining the healthy anatomy of the patient. Multiple aspects of oncofertility were discussed in the hour-long seminar, including options to freeze patients' eggs/sperm before cancer treatment, the management of sex hormone levels in cancer survivors, and the promotion of research and communication in oncofertility. In addition to these ongoing developments, research is being conducted on alternative cancer treatment strategies. The objective is to develop a patient-friendly infrastructure to facilitate access to available technologies. The seminar highlighted the significance of educating cancer patients about oncofertility and the need for healthcare providers to provide comprehensive care.